"But this is part of a much deeper story - the uncertainty...
Category:
Health
Latest
77 pc employees think work-related stress can induce anxiety, depression: Report
The report further revealed that 82 per cent of the participants...
Climate change much deadlier than cancer in some places, UNDP data shows
The data shows that climate change could increase mortality rates...
General insurers receive 900 Covid-19 claims for Rs 18 cr
The general insurance companies have received 900 claims for over Rs 17 crore for Covid-19 treatment till Monday,according the General Insurance Council, the official representative body of the domestic general insurers.
Maharashtra at around 450 claims for about Rs 8 crore have remained at the top of the claim chart. The city of Mumbai itself has generated around 350 claims for around Rs 4 crore.
UK doctor alerts Indians to poor diet link with COVID-19 deaths
A recent report in the ‘Nature’ science journal revealed that patients with Type 2 diabetes and metabolic syndrome might have up to 10 times greater risk of death when they contract COVID-19 and called for mandatory glucose and metabolic control of Type 2 diabetes patients to improve outcomes.
All domestic, international flight operations suspended till 17 May
A DGCA circular further stated, “However, it is reiterated that foreign and domestic airlines shall be suitably informed about the opening of their operations whether international to/from India or domestic respectively in due course.”
Covid-19 Pandemic:Confirmed cases cross 40,000,1,323 dead,record 2,644 new cases detected in last 24 hours
In a significant milestone in its fight against the novel Coronavirus,India has completed over 1 million Covid-19 RT-PCR tests (Reverse Transcription-Polymerase Chain Reaction).According to ICMR, a total of 1046450 samples have been tested as on 03 May 2020, 9 AM IST.RT-PCR is the only diagnostic test for Covid-19 approved by the World Health Organization.India is current carrying out an average of 75,000 tests per day at 419 approved laboratories across the country.
Covid-19 will make life tough for non-life insurers: experts
“The Covid-19 will surely have its negative impact on the Indian non-life insurance industry as the lockdown is expected to continue in one way or other. There will be a drop in the business for the first quarter while improvement is expected in the second quarter of FY 21,” G. Srinivasan,Director, National Insurance Academy and former chairman-cum-managing director, New India Assurance
Asia prepares for everyday life with Covid
As cities in Asia, Australia and elsewhere get their coronavirus outbreaks underneath management, church buildings, faculties, eating places, film theaters and even sporting venues are beginning to open, creating a way of normalcy for individuals who have spent weeks and even months in isolation.
COVID-19 death toll rises to 1,218, cases to 37,336
A total of 66 deaths were reported since Friday evening of which 26 fatalities were reported from Maharashtra, 22 from Gujarat, eight from Madhya Pradesh, four from Rajasthan, two from Delhi and one each from Uttar Pradesh, Bihar, Haryana and Tamil Nadu.
Maharashtra to provide free & cashless health insurance cover to its people
Speaking to reporters after a Maharashtra Day event in Jalna on Friday, Tope said 85 per cent of the state’s population was covered under the Mahatma Jyotiba Phule Jan Arogya Yojana (MJPJAY) at present and the cover will be extended to the remining 15 per cent.A memorandum was signed to include government, semi-government employees and white ration card holders in the scheme in a bid to prevent private hospitals from overcharging patients, he said.
India extends nationwide lockdown,to allow relaxations in lower-risk zones
The biggest and most economically-important cities, including New Delhi, Mumbai, Bengaluru, Chennai and Ahmedabad, would all be classed as red zones, infection hotspots, and kept under strict lockdown.
Maker of coronavirus trial drug aims for wide distribution – Gilead CEO
Gilead Sciences, which manufactures remdesivir, is focused on making the experimental coronavirus drug accessible and affordable to as many people as possible once it is approved, Chief Executive Officer Daniel O’Day said on Friday. Interest in...